This federal contract award, valued at $34,576.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award, which is a Delivery Order contract with a Firm Fixed Price pricing type, covers the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of December 17, 2024.
This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/23/25, 12:48 AM